卡度尼利单抗
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Cadonilimab)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Anti-Human PD-1xCTLA-4 Bispecific Antibody(Cadonilimab)
CAS2394841-59-7
Storage condition -80°C for one-year storage. Avoid repeated freeze-thaw.
Security information
Product details

Cadonilimab is a pioneering bispecific antibody targeting PD-1 and CTLA-4,it blocks both PD-1 and CTLA-4 pathways, thereby relieving their corresponding immunosuppressive effects and reversing tumor specific T cell exhaustion. Cadonilimab significantly downregulates Fc-mediated effector functions, including antibody-dependent cell-mediated cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement dependent cytotoxicity (CDC). Cadonilimab can be used for research of metastatic cervical cancer, as well as other malignancies such as gastric cancer, GEJ adenocarcinoma and non-small cell lung cancer (NSCLC).

Related literature
Related
Sorry, no related items
History
Ailanthone
Anti-Human PD-1xCTLA-4 Bispecific Antibody(Cadonilimab)
Labetalol Hydrochloride
Geniposide (Synonyms: 栀子苷; 京尼平苷)
Saponins | Saponin | Sapogenins Glycosides
Brefeldin A (Synonyms: BFA ; Cyanein ; Decumbin)
Theaflavin; 3,4,5-trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-6-one